William Lapps

618 total citations
15 papers, 508 citations indexed

About

William Lapps is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, William Lapps has authored 15 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Animal Science and Zoology and 5 papers in Epidemiology. Recurrent topics in William Lapps's work include Viral gastroenteritis research and epidemiology (6 papers), Animal Virus Infections Studies (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). William Lapps is often cited by papers focused on Viral gastroenteritis research and epidemiology (6 papers), Animal Virus Infections Studies (6 papers) and Cytomegalovirus and herpesvirus research (5 papers). William Lapps collaborates with scholars based in United States, Malaysia and Germany. William Lapps's co-authors include David A. Brian, Brenda G. Hogue, James E. Whitman, Mark H. Kaplan, Dharam V. Ablashi, J R Richert, Gary R. Pearson, Louise G. Chatlynne, H. Phillip Koeffler and Rizwan Masood and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Clinical Microbiology.

In The Last Decade

William Lapps

15 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Lapps United States 9 309 208 198 195 63 15 508
Elizabeth C. Coronel United States 10 149 0.5× 219 1.1× 50 0.3× 31 0.2× 85 1.3× 14 495
Nancy Casteel United States 7 257 0.8× 97 0.5× 19 0.1× 248 1.3× 66 1.0× 9 453
Stina L. Urban United States 8 60 0.2× 132 0.6× 82 0.4× 14 0.1× 26 0.4× 12 508
Seijiro Uchida Japan 10 79 0.3× 47 0.2× 244 1.2× 36 0.2× 139 2.2× 24 438
Gregory T. Melroe United States 11 37 0.1× 266 1.3× 81 0.4× 20 0.1× 33 0.5× 13 473
Jayeeta Dhar United States 8 90 0.3× 113 0.5× 41 0.2× 33 0.2× 27 0.4× 10 441
K. G. Warren Canada 9 33 0.1× 281 1.4× 46 0.2× 21 0.1× 58 0.9× 10 338
Ferran Soldevila United States 10 85 0.3× 34 0.2× 30 0.2× 90 0.5× 48 0.8× 14 224
Daniel Wells United Kingdom 7 165 0.5× 42 0.2× 31 0.2× 62 0.3× 125 2.0× 11 532
Wen Xia China 9 104 0.3× 190 0.9× 22 0.1× 18 0.1× 16 0.3× 40 408

Countries citing papers authored by William Lapps

Since Specialization
Citations

This map shows the geographic impact of William Lapps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Lapps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Lapps more than expected).

Fields of papers citing papers by William Lapps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Lapps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Lapps. The network helps show where William Lapps may publish in the future.

Co-authorship network of co-authors of William Lapps

This figure shows the co-authorship network connecting the top 25 collaborators of William Lapps. A scholar is included among the top collaborators of William Lapps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Lapps. William Lapps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Coller, Beth-Ann, William Lapps, Samantha Bruno, et al.. (2022). Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines. Vaccines. 10(9). 1446–1446. 6 indexed citations
2.
Wolf, Jayanthi, et al.. (2020). The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases. Vaccine. 38(46). 7198–7200. 1 indexed citations
3.
Tell, Joan G., Beth-Ann Coller, Sheri Dubey, et al.. (2020). Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease. Vaccines. 8(4). 779–779. 7 indexed citations
4.
Ablashi, D. V., John G. Bernbaum, Louise G. Chatlynne, et al.. (1998). Propagation and characterization of human herpesvirus-7 (HHV-7) isolates in a continuous T-lymphoblastoid cell line (SupT1). Journal of Virological Methods. 73(2). 123–140. 13 indexed citations
5.
6.
Ablashi, D. V., Louise G. Chatlynne, William Lapps, et al.. (1998). HUMAN HERPESVIRUS-8 (HHV-8) COMPARATIVE SERO-PREVALENCE IN U.S.A., INDIA, THAILAND, MALAYSIA, AND ITS ASSOCIATION WITH MALIGNANCIES.. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A25–A25. 2 indexed citations
7.
Ablashi, Dharam V., William Lapps, Mark H. Kaplan, et al.. (1998). Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Multiple Sclerosis Journal. 4(6). 490–496. 93 indexed citations
8.
Ablashi, D. V., Louise G. Chatlynne, William Lapps, et al.. (1997). HUMAN HERPESVIRUS-8 (HHV-8). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A23–A23. 4 indexed citations
9.
Lapps, William, et al.. (1990). Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site. Virology. 176(1). 296–301. 1 indexed citations
10.
11.
Lapps, William, John Eng, A S Stern, & Ueli Gubler. (1988). Expression of porcine cholecystokinin cDNA in a murine neuroendocrine cell line. Proteolytic processing, sulfation, and regulated secretion of cholecystokinin peptides.. Journal of Biological Chemistry. 263(26). 13456–13462. 34 indexed citations
12.
Lapps, William, Brenda G. Hogue, & David A. Brian. (1987). Deduced Amino Acid Sequence and Potential O-Glycosylation Sites for the Bovine Coronavirus Matrix Protein. Advances in experimental medicine and biology. 218. 123–129. 8 indexed citations
13.
Lapps, William, Brenda G. Hogue, & David A. Brian. (1987). Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genes. Virology. 157(1). 47–57. 135 indexed citations
14.
Kapke, Paul A., et al.. (1987). Diagnosis of porcine and bovine enteric coronavirus infections using cloned cDNA probes. Journal of Clinical Microbiology. 25(9). 1591–1596. 34 indexed citations
15.
Lapps, William & David A. Brian. (1985). Oligonucleotide fingerprints of antigenically related bovine coronavirus and human coronavirus OC43. Archives of Virology. 86(1-2). 101–108. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth C. Coronel Breakdown of academic impact, for papers by Nancy Casteel Breakdown of academic impact, for papers by Stina L. Urban Breakdown of academic impact, for papers by Seijiro Uchida Breakdown of academic impact, for papers by Gregory T. Melroe Breakdown of academic impact, for papers by Jayeeta Dhar Breakdown of academic impact, for papers by K. G. Warren Breakdown of academic impact, for papers by Ferran Soldevila Breakdown of academic impact, for papers by Daniel Wells Breakdown of academic impact, for papers by Wen Xia
Rankless by CCL
2026